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A B S T R A C T
Background
The standard duration of treatment for children with acute group A beta hemolytic streptococcus (GABHS) pharyngitis with oral
penicillin is 10 days. Shorter duration antibiotics may have comparable efficacy.
Objectives
To summarize the evidence regarding the efficacy of two to six days of newer oral antibiotics (short duration) compared to 10 days of
oral penicillin (standard duration) in treating children with acute GABHS pharyngitis.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2012, Issue 3) which contains the Cochrane Acute
Respiratory Infections Group’s Specialized Register, MEDLINE (January 1966 to March week 3, 2012) and EMBASE (January 1990
to April 2012).
Selection criteria
Randomized controlled trials (RCTs) comparing short duration oral antibiotics to standard duration oral penicillin in children aged 1
to 18 years with acute GABHS pharyngitis.
Data collection and analysis
Two review authors scanned the titles and abstracts of retrieved citations and applied the inclusion criteria. We retrieved included
studies in full, and extracted data. Two review authors independently assessed trial quality.
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Main results
We included 20 studies with 13,102 cases of acute GABHS pharyngitis. The updated search did not identify any new eligible studies;
the majority of studies were at high risk of bias. However, the majority of the results were consistent. Compared to standard duration
treatment, the short duration treatment studies had shorter periods of fever (mean difference (MD) -0.30 days, 95% confidence interval
(CI) -0.45 to -0.14) and throat soreness (MD -0.50 days, 95% CI -0.78 to -0.22); lower risk of early clinical treatment failure (odds
ratio (OR) 0.80, 95% CI 0.67 to 0.94); no significant difference in early bacteriological treatment failure (OR 1.08, 95% CI 0.97
to 1.20) or late clinical recurrence (OR 0.95, 95% CI 0.83 to 1.08). However, the overall risk of late bacteriological recurrence was
worse in the short duration treatment studies (OR 1.31, 95% CI 1.16 to 1.48), although no significant differences were found when
studies of low dose azithromycin (10 mg/kg) were eliminated (OR 1.06, 95% CI 0.92 to 1.22). Three studies reported long duration
complications. Out of 8135 cases of acute GABHS pharyngitis, only six cases in the short duration treatment versus eight in the
standard duration treatment developed long-term complications in the form of glomerulonephritis and acute rheumatic fever, with no
statistically significant difference (OR 0.53, 95% CI 0.17 to 1.64).
Authors’ conclusions
Three to six days of oral antibiotics had comparable efficacy compared to the standard duration 10-day course of oral penicillin in
treating children with acute GABHS pharyngitis. . In areas where the prevalence of rheumatic heart disease is still high, our results
must be interpreted with caution.
P L A I N L A N G U A G E S U M M A R Y
The effect of short duration versus standard duration antibiotic therapy for streptococcal throat infection in children
Streptococcal (strep) throat infection is very common. A 10-day course of penicillin is prescribed mainly to protect against the
complication of acute rheumatic fever, which can occur approximately 20 days after streptococcal throat and cause damage to the
heart valves. Cases of acute rheumatic fever have dropped dramatically in high-income countries. Newer antibiotics taken for a shorter
duration, may have a comparable effect to penicillin taken for 10 days.
We summarized medical literature regarding the effect of two to six days of oral antibiotics (short duration) in treating children with
streptococcal throat infection, compared with 10 days of oral penicillin (standard duration). We included 20 studies with 13,102 cases
of acute group A beta hemolytic streptococcus (GABHS) pharyngitis. The short duration treatment resulted in better compliance but
more side effects. All side effects were self-limiting: mostly mild to moderate diarrhea, vomiting and abdominal pain. Three studies
reported the rate of long duration complications with no statistically significant difference.
Our study has several limitations. Firstly, only 3 out of the 20 included studies followed the participants for a sufficient duration to be able
to study the prevalence of complications of GABHS pharyngitis. Although these three studies had a total of 8135 participants, results
were too under-powered to draw any conclusions on differences in complication rates. This means our conclusion is not applicable in
low-income countries where the prevalence of rheumatic heart disease is high. Another limitation is that the primary studies evaluated
different antibiotics for variable durations (three to six days). Also, studies were of limited quality. Finally, although the shorter antibiotic
duration appeared to be effective and more convenient, it is more expensive than the standard duration 10 days of penicillin. However,
one must take into account the reality of patient behavior and the price of unsuccessful or incomplete therapy.
Three to six days of oral antibiotics for children with streptococcal throat infection is a safe treatment with a comparable effect to the
standard duration of 10 days of penicillin. However, our results must be interpreted with caution in low-income countries where acute
rheumatic fever is still a problem.
B A C K G R O U N D
Description of the condition
Sore throat is one of the most common symptoms that primary
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health care physicians have to deal with (Nandi 2001) and group
A beta hemolytic streptococcus (GABHS) is the most common
bacterial cause. Fifty per cent of cases are in children between the
ages of 5 and 15 years (Bisno 1997). Although patients recover
without antibiotic therapy, treatment is sometimes advised to has-
ten clinical resolution, prevent suppurative sequelae and decrease
the incidence of rheumatic fever and glomerulonephritis (Bisno
1997). Rheumatic fever is a systemic disease affecting the peri-
arteriolar connective tissue and can occur after an untreated group
A streptococcal pharyngeal infection. It is believed to be caused by
antibody cross-reactivity and leads to pancarditis (inflammation of
the heart layers). Chronic rheumatic heart disease leads to cardinal
anatomic changes of the valve including leaflet thickening, com-
missural fusion and shortening and thickening of the tendinous
cords (Kumar 2008).
Description of the intervention
Many antibiotics have been shown to be effective in treating
GABHS pharyngitis, including penicillin and its congeners (such
as ampicillin, amoxicillin and semi-synthetic penicillins) as well as
many cephalosporins, macrolides and clindamycin (Bisno 1997).
Penicillin is often chosen because of its proven efficacy, safety, nar-
row spectrum and low cost. Oral penicillin for 10 days is still rec-
ommended as standard of care, because of past concern for maxi-
mum protection against acute rheumatic fever (the principal and
original reason for using antibiotics for sore throat). However, a
shorter duration of newer antibiotics, such as cephalosporins, has
been shown to have comparable efficacy and has the advantage
of overcoming beta lactamase producing organisms, as well as a
longer half life, as with azithromycin. The incorporation of poten-
tially more costly treatments in the era of health care reform must
take into account the reality of patient behavior and the price of
unsuccessful or incomplete therapy.
How the intervention might work
It is difficult to comply with a 10-day antibiotic course. If we
summarize the available evidence and show that a short duration
antibiotic course is efficacious in treatingGABHSpharyngitis, this
will make treatment much more convenient to the patient and
will improve compliance.
Why it is important to do this review
A 10-day course of antibiotics has variable patient compliance
(Cohen 1996), possibly because symptomatic improvement is of-
ten achieved within 24 to 48 hours of starting therapy. Patient
(or parent) motivation to complete the recommended 10 day du-
ration of penicillin diminishes rapidly after two to three days.
Greater convenience to patients may result in improved compli-
ance (Cohen 1996); and reduced failure rate (Adam 2000a; Tack
1997), complications (Tack 1997) and returns to the physician
(Adam 2000a); and overall cost (Adam 2000a; Cohen 1996; Tack
1997).
O B J E C T I V E S
To summarize the evidence regarding the effect of 2 to 6 days of
oral antibiotics in treating children with group A beta hemolytic
streptococcus (GABHS) pharyngitis, compared with a 10-day
course of oral penicillin, on duration of symptoms (fever and sore
throat), eradication of the organism and recurrence and compli-
cation rates (acute rheumatic fever and acute poststreptococcal
glomerulonephritis). We considered differences in reported side
effects, for example diarrhea, yeast infections, gastrointestinal up-
set and rash.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomized controlled trials (RCTs) only.
Types of participants
Children, 1 to 18 years of age, with documented acute streptococ-
cal pharyngitis, based on a positive rapid antigen testing or posi-
tive throat swab culture for GABHS, conducted in the emergency
department or physician’s office (general practitioner, pediatrician
or otolaryngologist). We excluded studies on GABHS carriers and
studies using tools other than rapid antigen testing or throat swab
culture to document GABHS pharyngitis.
Types of interventions
Short duration (two to six days) of oral antibiotics versus a con-
trol of 10 days of oral penicillin (i.e. the recommended standard
duration of treatment). We excluded studies comparing short du-
ration antibiotics with 10 days of antibiotics other than penicillin.
We selected 10 days of penicillin to be the control as it remains
the recommended standard care due to its proven efficacy, narrow
spectrum and low cost.
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Types of outcome measures
Primary outcomes
1. The number of days to resolution of fever and sore throat.
Secondary outcomes
1. Early clinical treatment failure, defined as persistent sore
throat, fever or both in the first two weeks after completion of
antibiotic treatment.
2. Late clinical recurrence, defined as recurrence of sore throat,
fever or both after initial resolution, beyond the two-week period
immediately after completion of antibiotic treatment.
3. Early bacteriological treatment failure, defined as
persistence of the same GABHS strain in the first two weeks after
completion of antibiotic treatment.
4. Late bacteriological recurrence, defined as recurrence of the
same GABHS strain after initial resolution, beyond the two-week
period immediately after completion of antibiotic treatment.
5. Compliance.
6. Acute rheumatic fever.
7. Acute poststreptococcal glomerulonephritis.
8. Suppurative and non-suppurative complications.
9. Differences in reported side effects, for example diarrhea,
yeast infections, gastrointestinal upset and rash.
Search methods for identification of studies
Electronic searches
Originally we searched the Cochrane Central Register of Con-
trolled Trials (CENTRAL) (The Cochrane Library 2007, Issue 4)
and the Database of Abstracts of Reviews of Effects (DARE),
MEDLINE (1966 to October, Week 5 2007), OLDMEDLINE
(1950 to December 1965) and EMBASE (January 1990 to
November 2007) (Appendix 1).
For this update we searched theCochraneCentral Register of Con-
trolled Trials (CENTRAL) (The Cochrane Library 2012, Issue 3;
www.thecochranelibrary.com (accessed 3 April 2012), which con-
tains the Cochrane Acute Respiratory Infections Group’s Special-
ized Register, MEDLINE (January 2007 to March week 3, 2012)
and EMBASE (January 2007 to April 2012).
We combined the MEDLINE search string shown in Appendix 2
with theCochraneHighly Sensitive Search Strategy for identifying
randomized trials in MEDLINE: sensitivity and precision-maxi-
mizing version (2008 revision); Ovid format (Lefebvre 2011). We
adapted the search string for EMBASE (Appendix 3).
Searching other resources
We did not impose any language or publication restrictions. We
identified any other reviews (systematic and narrative) or meta-
analyses on this topic (Thornton 2000) in addition to identify-
ing relevant clinical trials. We checked the bibliography of pub-
lished RCTs, asked experts for trial information and we con-
tacted pharmaceutical companies. We searched conference ab-
stract proceedings, ISI Web of Science, the System for Infor-
mation on Grey Literature in Europe (SIGLE) and the British
Library Index of Conference Proceedings. We also searched
www.clinicaltrials.gov, Computer Retrieval of Information on Sci-
entific Projects (CRISP),META and the GlaxoWellcomeRegister
of clinical trials for ongoing and/or unpublished studies.
Data collection and analysis
Selection of studies
Two review authors (KK, AK) independently performed the ini-
tial scan using titles and abstracts of all retrieved citations and ap-
plied the inclusion criteria. Both review authors documented the
reasons for study exclusion and retrieved potentially eligible trials
in full. We assessed trials fulfilling the review inclusion criteria for
quality (Chalmers 1981; Meade 1997). We calculated inter-rater
agreement using Kappa statistics. We resolved disagreements by
consensus. Two authors (SA, MA) independently performed the
updated scan and selection of studies using the samemethodology
as in the initial review.
Data extraction and management
We divided the study into two or more studies whenever it had
more than two treatment arms, each comparing one intervention
against the control (for example, Cohen 2002a; Cohen 2002b).
Two review authors (KK, AK) independently collected and com-
pared the following data using a standardized data collection form.
We resolved differences by consensus.
Characteristics of participants
Number of participants, age, race and gender.
Characteristics of intervention
Type of antibiotic, dose, schedule and length of follow-up.
Characteristics of outcome measures
Duration of fever and sore throat, clinical treatment failure, bacte-
riological treatment failure, recurrence rate, rate of complications,
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including glomerulonephritis and acute rheumatic fever and sup-




Assessment of risk of bias in included studies
Two review authors (SA, AK) independently assessed the risk of
bias usingTheCochraneCollaboration’s ’risk of bias’ tool (Higgins
2011) which assesses methodological quality according to:
• random sequence generation;
• allocation concealment;
• blinding of participants and personnel;
• blinding of outcome assessment;
• incomplete outcome data;
• selective reporting; and
• other bias.
We resolved disagreement by consensus. We included all eligible
studies in the analysis.
Measures of treatment effect
We expressed continuous data as mean differences (MDs) and
calculated an overall MD. We expressed dichotomous data as an
odds ratio (OR). We reported occurrence of complications during
the study period.
Unit of analysis issues
We defined several different outcomes (time to fever resolution,
time to sore throat resolution, early clinical treatment failure, late
clinical recurrence, early bacteriological treatment failure, late bac-
teriological recurrence, adverse effects, compliance and complica-
tions) based on different periods of follow-up. We performed sep-
arate analyses. We analyzed studies that compared more than two
intervention groups (if meeting the inclusion criteria) by making
multiple pair-wise comparisons. We did not include any partici-
pants twice.
Dealing with missing data
We analyzed only the available data. We assumed the data to be
missing at random and unlikely to be related to the actual values
of the missing data.
Assessment of heterogeneity
We tested for heterogeneity using the Z score, the Chi2 test and
the I2 statistic with values greater than 50% indicating substantial
heterogeneity.
Assessment of reporting biases
We tested for publicationbias and small study effects using a funnel
plot.
Data synthesis
We conducted a meta-analysis using the fixed-effect model.
Subgroup analysis and investigation of heterogeneity
We divided the studies into five subgroups according to the inter-
vention antibiotic: azithromycin 10 mg/kg, azithromycin 20 mg/
kg, clarithromycin, cefuroxime and others. We compared its per-
formance against all identified outcomes of interest.
Sensitivity analysis
We did not perform a sensitivity analysis
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
Two review authors (KK, AK) independently searched for relevant
trials. (KK’s electronic search yielded 915 citations and AK’s search
yielded 917). After the initial scan of the titles and abstracts, 98
trials were preliminarily eligible on KK’s list and 115 on AK’s list,
scoring a fair inter-observer allocation agreement (kappa = 0.61).
After consensus, we agreed upon an initial combined list of 97
eligible studies and we retrieved the studies in full. We identified
and retrieved 10 further citations from the reference lists of these
studies. We did not find any additional trials in relevant system-
atic reviews or from our contact with experts and pharmaceutical
companies. We found an abstract of one eligible unpublished trial,
presented at a scientific meeting. However, data from that study
were not available from the principal investigator. Two review au-
thors (SA, AK) independently performed the updated search and
found no new eligible studies.
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Included studies
We assessed 107 trials for inclusion. Eighty-six trials did not meet
our inclusion criteria, which left 21 eligible published clinical tri-
als. We excluded one further study (Adam 2000b) because it was
a re-publication of part of the data published in a larger study
(Adam 2000a), which is included in the review.
Twenty RCTs met our inclusion criteria and we included them
in the review. These trials investigated a total of 13,102 cases of
group A beta hemolytic streptococcus (GABHS) throat infections
(tonsillitis, pharyngitis, tonsillopharyngitis). Themajority of stud-
ies were recent (1994 to 2004), during which period the rates of
serious complications (especially acute rheumatic fever) were less
common than before. The age of participants ranged from 1 to
18 years, with the exception of one study which included partic-
ipants aged up to 25 years. All studies recruited participants pre-
senting with signs and symptoms of tonsillopharyngitis and pos-
itive rapid GABHS antigen test of throat swab. The most com-
mon intervention antibiotic was azithromycin (n = 6). Other in-
tervention antibiotics were cefuroxime (n = 3), erythromycin (n
= 2), clarithromycin (n = 3), cefixime (n =1), amoxacillin (n = 1),
amoxacillin/clavulanate (n = 2), penicillin V (n =1), cefprozil (n
= 1), cefpodoxime (n = 1), josamycin (n = 1), cefdinir (n = 1),
ceftibuten (n = 1) and loracarbef (n = 1).
Excluded studies
We excluded one study (Adam 2000b), because it was a republica-
tion of part of the data that was published in a larger study (Adam
2000a).
Risk of bias in included studies
All studies showed random assignment, per our inclusion criteria.
Ranomization was mostly not concealed or unclear. All studies
were analyzed by treatment received rather than by an intention-
to-treat analysis and all studiesmentionedwithdrawals.Only three
studies were blinded (O’Doherty 1996a; Pichichero 1994; Tack
1997). All studies had a standardized assessment (Figure 1; Figure
2).
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Figure 1. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
Thirteen studies used an open, random allocation and seven had
insufficient information to permit judgment. Eleven studies used
computer generated randomizations, while nine were unclear.
Blinding
Only three studies were blinded (O’Doherty 1996a; Pichichero
1994; Tack 1997). The risk of bias can be significant in assessing
outcomes that are subjective in nature like resolution of symptoms
and clinical failure, or reporting of side effects and complications.
Incomplete outcome data
Eight out of 20 studies were at high risk for attrition bias, due
mostly to significant missing outcome data.
Selective reporting
All studies were at low risk for reporting bias, as study protocols
were all available and all prespecified outcomes have been reported.




Our primary outcome was time to fever resolution as it is themain
presenting symptom and the most common symptom of concern
for parents. The time to fever resolution was reported in only two
studies (Aujard 1995; Kafetzis 2004). Both studies favored the
short duration group. In the first study, the short duration group
had a mean duration of fever of 2.04 days compared with 2.38
days in the standard duration group, while in the second study
the durations were 2.82 days and 3.1 days, respectively (mean
difference (MD) -0.30, 95% confidence interval (CI) -0.45 to -
0.14) (Analysis 1.1).
Secondary outcomes
Sore throat is a complication of pharyngitis that commonly causes
patient discomfort and may cause difficulty in drinking. Time
to sore throat resolution was reported in only one study (Aujard
1995). The MD of sore throat was 2.19 days (standard deviation
(SD) 0.81) in the short duration treatment group and 2.69 days
(SD 1.13) in the standard duration treatment group (MD -0.50,
95% CI -0.78 to -0.22) (Analysis 1.2).
Early clinical treatment failure
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All included studies except Milatovic 1991 reported risk of early
clinical treatment failure (1 to 10 days after completion of the
antibiotic duration) but only two studies (Aujard 1995; Kafetzis
2004) gave details about specific clinical signs and symptoms. The
short duration treatment group showed a lower risk of early clinical
treatment failure (odds ratio (OR) 0.80, 95% CI 0.67 to 0.94)
(Analysis 2.1).
Late clinical recurrence
Thirteen studies assessed the risk of late clinical recurrence. The
majority of the studies performed follow-up four weeks after com-
pletion of treatment, with a range from two weeks to one year in
one study. The risk of late clinical recurrence was not statistically
different between short duration and standard duration groups
(OR 0.95, 95% CI 0.83 to 1.08) (Analysis 2.2).
Early bacteriological treatment failure
Bacterial eradication is important in order to reduce the chance of
recurrence and GABHS complications, especially acute rheumatic
fever and glomerulonephritis. All included studies assessed risk of
early (1 to 10 days) bacteriological treatment failure. There was no
significant difference in the risk of early bacteriological treatment
failure between short duration and standard duration groups (OR
1.08, 95% CI 0.97 to 1.20) (Analysis 3.1).
Late bacteriological recurrence
All studies assessed the risk of late (four to six weeks) bacteriolog-
ical recurrence. The risk of late bacteriological recurrence was sig-
nificantly worse in the short duration treatment groups (OR 1.31,
95% CI 1.16 to 1.48). However, when eliminating the studies of
low dose azithromycin (10 mg/kg), which performed much worse
than other short duration regimens (OR 3.62, 95% CI 2.66 to
4.92), the two treatment groups were no longer statistically differ-
ent (OR 1.06, 95% CI 0.92 to 1.22).
Adverse effects
All but three studies (Adam 2000a; Gerber 1987; Milatovic 1991)
reported side effects.More side effects were seen in the short dura-
tion treatment group (OR 1.85, 95% CI 1.55 to 2.21) (Analysis
4.1). All side effects were mild tomoderate and self-limiting. Most
of the events involved the gastrointestinal system (diarrhea, vom-
iting and abdominal pain) in both treatment groups.
Compliance
Five studies reported patient compliance with the study treatment
(Adam 1996; Aujard 1995; Cohen 1996; Cohen 2002a; Cohen
2002b;McCarty 2000).Non-compliance was reduced in the short
duration treatment group (OR 0.21, 95% CI 0.16 to 0.29).
Complications
Only three studies reported post-GABHS pharyngitis compli-
cations. In the Adam 2000a study, 5 out of 4482 participants
with a 12-month follow-up period developed complications. In
the short duration treatment group three participants developed
acute rheumatic fever and one developed glomerulonephritis. In
the standard duration treatment group one patient developed
glomerulonephritis.
In the Schaad 2002 study, two participants in the short duration
treatment group developed proteinuria or glomerulonephritis and
six participants in the standard duration treatment group devel-
oped proteinuria and/or glomerulonephritis or reactive arthritis.
These findings disappeared without treatment within one to three
weeks.
In the Scholz 2004 study, one patient in the standard duration
treatment group developed glomerulonephritis.
Overall, there was no statistically significant difference in the risk
of complications (OR 0.53, 95% CI 0.17 to 1.64).
Subgroup analysis
Due to the limited number of trials that assessed the same drug
for short treatment we focused on the overall effect. However, we
have included in the analysis figures that show the effect per drug
for four subsets of studies based on the type of short duration
antibiotic used: azithromycin 10 mg/kg, azithromycin 20 mg/kg,
clarithromycin and cefuroxime.
Small study effect
Weused funnel plots to check small study effect and reporting bias
(Figure 3; Figure 4). No asymmetry was evident from examining
these plots.
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Figure 3. Funnel plot of comparison: 2 Clinical efficacy, outcome: 2.1 Clinical treatment failure (early).
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Figure 4. Funnel plot of comparison: 2 Clinical efficacy, outcome: 2.2 Clinical treatment failure (late).
D I S C U S S I O N
Ona global scale, group A beta hemolytic streptococcus (GABHS)
infection is an important cause of morbidity andmortality. In low-
income countries rheumatic fever remains an endemic disease with
an annual incidence ranging from 100 to 200 per 100,000 school-
aged children and is a major cause of cardiovascular mortality
(Olivier 2000). The global burden of disease caused by GABHS is
not known. A report by theCentre for International ChildHealth,
University of Melbourne, reviewed recent population-based data
in order to estimate the burden of GABHS diseases (Carapetis
2005). The report highlighted deficiencies in the available data
and found that there are at least 517,000 deaths annually due
to severe GABHS diseases (for example, acute rheumatic fever,
rheumatic heart disease, poststreptococcal glomerulonephritis and
invasive infections). The prevalence of severe GABHS disease is
at least 18.1 million cases, with 1.78 million new cases each year.
The greatest burden is due to rheumatic heart disease, with a
prevalence of at least 15.6 million cases, with 282,000 new cases
and 233,000 deaths each year. The burden of invasive GABHS
diseases is unexpectedly high, with at least 663,000 new cases and
163,000 deaths each year. The report states that there are more
than 111 million prevalent cases of GABHS pyoderma and over
616 million cases of GABHS pharyngitis per year.
The incidence of rheumatic fever has declined in high-income
countries since the 1950s and now has an annual incidence of
around0.5 cases per 100,000 children of school age. The incidence
of acute rheumatic fever in the United States, particularly over the
past 50 years has decreased substantially. The reason for this is un-
clear. It has been proposed that certainM types ofGABHS include
strains that are particularly rheumatogenic and that others are non-
rheumatogenic. Shulman 2006 compared theM type distribution
of GABHS recovered from children in Chicago, Illinois with acute
pharyngitis between 1961 and 1968 to that of GABHS recovered
from Chicago children and children from across the United States
between 2000 and 2004, with attention to changes in M types
that were previously associated with rheumatogenic strains. Shul-
man found rheumatogenic types comprised 49.7% of 468 pha-
ryngeal isolates between 1961 and 1968 but only 10.6% of 450
Chicago isolates and 17.9% of 3969 isolates nationwide between
2000 and 2004 (P < 0.001). These data support the concept of
rheumatogenic strains of GABHS and indicate that the marked
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decrease in the incidence of acute rheumatic fever in the United
States over the past four decades is correlated with the replacement
of rheumatogenic types by non-rheumatogenic types in cases of
acute GABHS pharyngitis in children. The reasons underlying the
observed change in distribution ofM types remain to be explained
(Shulman 2006).
The standard duration 10 days of penicillin in treating children
with acute GABHS pharyngitis is difficult to comply with. We
have shown in this systematic review that a short duration (three
to six days) of oral antibiotics has comparable efficacy to the stan-
dard 10-day duration of oral penicillin. The two regimes showed
comparable results, including time to resolution of fever and sore
throat, risk of early clinical and bacteriological treatment failure,
late clinical and bacteriological recurrence and risk of complica-
tions. The short duration treatment was superior with regard to
compliance. Low dose azithromycin (10mg/kg/day) for three days
was significantly inferior to standard duration treatment and other
short duration treatments with regard to bacteriological eradica-
tion. There were more side effects with the short duration treat-
ment, however, all were self-limiting and mainly mild to moderate
vomiting, diarrhea or abdominal pain.
We were struck by the wide range of antibiotic regimens studied.
Fourteen different antibiotic regimens were tried in the 20 studies
that met our inclusion criteria. In addition, short duration treat-
ment included regimens as brief as three days.
Our study has several limitations. Firstly, only 3 out of the 20 in-
cluded studies followed the participants for a sufficient duration to
be able to study the prevalence of complications of acute GABHS
pharyngitis (Adam 2000a; Schaad 2002; Scholz 2004). Although
these three studies had a total of 8135 participants, results were too
under-powered to draw any conclusions on differences in compli-
cation rates. This means our conclusion is not applicable in low-
income countries where the prevalence of rheumatic heart disease
is high. Another limitation is that the primary studies were het-
erogeneous. They studied different antibiotics for variable dura-
tions (three to six days). Also, studies had limited quality. Finally,
although the shorter antibiotic duration appeared to be effective
and more convenient, it is more expensive than the standard du-
ration 10 days of penicillin. However, one must take into account
the reality of patient behavior and the price of unsuccessful or in-
complete therapy.
Summary of main results
We included 20 studies with 13,102 cases of acute GABHS
pharyngitis. The updated search did not identify any new eligi-
ble studies. Compared to standard duration treatment, the short
duration treatment had shorter periods of fever and throat sore-
ness and lower risk of early clinical treatment failure. There was
no significant difference in early bacteriological treatment failure,
or late clinical recurrence, however, the overall risk of late bacte-
riological recurrence was worse in the short duration treatment
group, although no significant differences were found when stud-
ies of low dose azithromycin (10mg/kg) were eliminated. Three
studies reported long duration complications with no statistically
significant difference.
The outstanding uncertainty is in the difference of the risk of late
complications. In areas where the risk of rheumatic heart disease is
high, the risk may outweigh the benefit of improved convenience
and compliance with short duration antibiotics.
Overall completeness and applicability of
evidence
We included 20 studies with 13,102 cases of acute GABHS
pharyngitis. All included studies were very relevant to the objec-
tives of our review. The studies did not achieve enough power to
make any conclusions on the comparison of complication rates
of acute rheumatic fever and acute poststreptococcal glomeru-
lonephritis.
Quality of the evidence
A significant number of studies were at high risk for selection bias,
performance bias, detection bias and attrition bias. Most studies
used unconcealed randomization methods and were not blinded.
The majority of the results from one study to the other however,
were consistent.
Potential biases in the review process
Weattempted to identify every relevant trial using a rigorous search
strategy. Two authors independently applied the same search
methodology and resolved disagreement by consensus. Publica-
tion bias may be considered a potential threat to the validity of
results.
Agreements and disagreements with other
studies or reviews
In a recent Cochrane review of 27 trials, antibiotics were found
to reduce sore throat symptoms by about 16 hours and protect
against suppurative and non-suppurative complications (Spinks
2011). In another Cochrane review, the authors found insufficient
evidence for clinically meaningful differences between antibiotics
for GABHS tonsillopharyngitis (Van Driel 2010).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Three to six days treatment with oral antibiotics has comparable
efficacy to the standard duration 10 days of oral penicillin in treat-
ing children with acute GABHS pharyngitis. The shorter duration
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of antibiotic treatment can be more convenient for the patient,
and will improve compliance. If the clinician chooses azithromy-
cin for three days, a dose of 20 mg/kg/day should be used rather
than 10 mg/kg/day. No conclusions can be drawn on the com-
parison of complication rates of acute rheumatic fever and acute
poststreptococcal glomerulonephritis. In areas where the preva-
lence of rheumatic heart disease is still high, our results must be
interpreted with caution.
Implications for research
Large, international blinded randomized clinical trials with long-
term follow-up for at least 12months will be very valuable to com-
pare the difference in complication rates between short duration
and standard duration antibiotic regimes in treating children with
acute GABHS pharyngitis. Evaluating the efficacy of shorter du-
ration oral penicillin will also be very useful. The clinical and bac-
teriological efficacy of three to six days of newer antibiotic therapy
was comparable to that of the standard 10 days of penicillin; a
regimen that has a high non-compliance rate.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Adam 1995
Methods Open, controlled, randomized, multicenter trial
Participants 160 participants aged from 1 to 12 years; mean age 5.5 years
Interventions 1. Penicillin V 20,000 IU/kg tid for 10 days
2. Cefixime 8 mg/kg od for 5 days
Outcomes Clinical and bacteriological efficacy of study drugs. Secondary outcome was study med-
ication safety and tolerability
Notes Early follow-up: 1 to 5 days after the end of therapy
Late follow-up: 3 to 4 weeks after end of therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Based on computer-generated number”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data balanced in num-
bers across intervention groups, with simi-
lar reasons for missing data across groups
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
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Adam 1996
Methods Multicenter, randomized, open-label, controlled study
Participants 227 participants aged from 1 to 17 years; mean age 7.1 years. 103 males; 98 females
Interventions 1. Penicillin V 50,000 IU/kg (30 mg/kg) max. 2,225,000 IU tid for 10 days
2. Erythromycin estolate 40 mg/kg max. 1800 mg bid for 5 days
Outcomes Clinical and bacteriological efficacy of study drugs
Notes Early follow-up: 1 to 3 days after the end of therapy
Late follow-up: 6 +/- 2 weeks after the end of therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “according to a computer generated list to
receive either”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding or incomplete blinding and
the outcome is likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Noblinding of outcome assessment and the
outcome measurement is likely to be influ-
enced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data balanced in num-
bers across intervention groups, with simi-
lar reasons for missing data across groups
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
Adam 2000a
Methods Multicenter, randomized, open-label, controlled study
Participants 4782 participants aged 1 to 18 years; mean 6.1 years.Male/female 50.3%/49.7%.Weight
24.4 kg (9.2 to 79)
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Adam 2000a (Continued)
Interventions 1. Penicillin V 50,000 IU/kg/day (max. 2,250,000 IU) tid for 10 days
2. One of six antibiotics for 5 days:
• Amoxicillin/clavulanate 37.5 mg/kg/day (max. 1875 mg/day) tid
• Ceftibuten 9 mg/kg/day (max. 400 mg/day) od
• Cefuroxime axetil 20 mg/kg/day (max. 500 mg/day) bid
• Loracarbef 15 mg/kg/day (max. 400 mg/day) bid
• Clarithromycin 15 mg/kg/day (max. 500 mg/day) bid
• Erythromycin estolate 40 mg/kg/day (max. 1600 mg/day) bid
Outcomes Clinical and bacteriological efficacy of study drugs. And incidence of poststreptococcal
sequelae (rheumatic fever, acute glomerulonephritis)
Notes Early follow-up: 7 to 9 days after end of treatment
Late follow-up: 7 to 8 weeks, 6 months, 12 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Referred to a random number table
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Noblinding of outcome assessment and the
outcome measurement is likely to be influ-
enced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data balanced in num-
bers across intervention groups, with simi-
lar reasons for missing data across groups
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
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Aujard 1995
Methods Prospective, randomized, multicenter study
Participants 308 children aged 2 to 15 years; mean age 6.9 years. 92 males; 108 females
Interventions 1. Penicillin V 45 mg/kg/day, 3 divided doses for 10 days
2. Cefuroxime axetil 20 mg/kg/dose bid for 4 days
Outcomes Primary outcome was eradication of GABHS from throat culture obtained at the end
of treatment examination. Clinical outcome (success or failure). The time taken for
resolution of symptoms and safety analysis (side effects of each medication)
Notes Early follow-up: 2 to 4 days after completion of therapy
Late follow-up: 28 to 32 days after completion of therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “according to computer-generated lists”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk For dichotomous outcome data, the pro-
portion of missing outcomes compared
with observed event risk enough to induce
clinically relevant bias in intervention ef-
fect estimate
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
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Cohen 1996
Methods Prospective, comparative, open, randomized multicenter trial
Participants 321 patients aged 3 to 15 years; mean age 5.9. 153 males; 165 females
Interventions 1. Penicillin V 15 mg/kg/day tds for 10 days
2. Amoxicillin 25 mg/ kg/dose bid for 6 days
Outcomes Compare the clinical and bacteriological efficacy and safety of amoxicillin and penicillin
V in children with group A streptococcal tonsillopharyngitis
Notes Early follow-up: 4 days after completion of therapy
Late follow-up: 1 month after completion of therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “were assigned by means of a centralized
telephonic computer program”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding or incomplete blinding and
the outcome is likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Noblinding of outcome assessment and the
outcome measurement is likely to be influ-
enced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
High risk Reason for missing outcome data is likely
to be related to true outcome, with either
imbalance in numbers of reasons for miss-
ing data across intervention groups
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
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Cohen 2002a
Methods Prospective, comparative, randomized, multicenter trial
Participants 336 children aged 2 to 12 years; mean age 6 years. 181 males; 155 females
Interventions 1. Penicillin 15 mg/kg/dose tds for 10 days
2. Azithromycin 10 mg/kg/day od for 3 days
Outcomes The efficacy and tolerability of azithromycin compared with penicillin V
Notes Early follow-up: on day 14 +/- 2 of the study
Late follow-up: on day 30 +/- 4 of the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “assigned by means of a centralized tele-
phonic computer program”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding or incomplete blinding and
the outcome is likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Noblinding of outcome assessment and the
outcome measurement is likely to be influ-
enced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Reasons for missing outcome data unlikely
to be related to true outcome (for survival
data, censoring unlikely to be introducing
bias)
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
Cohen 2002b
Methods Prospective, comparative, randomized, multicenter trial
Participants 332 children aged 2 to 12 years. 175 males; 165 females
Interventions 1. Penicillin 15 mg/kg/dose tds for 10 days
2. Azithromycin 20 mg/kg/day od for 3 days
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Cohen 2002b (Continued)
Outcomes The efficacy and tolerability of azithromycin compared with penicillin V
Notes Early follow-up day 14 +/- 2 of the study
Late follow-up on day 30 +/- 4 of the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “assigned by means of a centralized tele-
phonic computer program”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding or incomplete blinding and
the outcome is likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Noblinding of outcome assessment and the
outcome measurement is likely to be influ-
enced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Reasons for missing outcome data unlikely
to be related to true outcome (for survival
data, censoring unlikely to be introducing
bias)
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
Gerber 1987
Methods Prospective, randomized, controlled study
Participants 210 children aged 3 to 25 years; mean age 9.8 years
Interventions 1. Penicillin V 250 mg/kg/dose tds for 10 days
2. Penicillin V 250 mg/kg/dose tds for 5 days
Outcomes Assess the clinical and bacteriological efficacy and compliance
Notes Early follow-up: 4 to 6 days following the completion of antibiotic therapy
Late follow-up: 2 to 3 weeks after completion of antibiotics
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Gerber 1987 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing outcome data
Allocation concealment (selection bias) Unclear risk Not mentioned
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
Hamill 1993
Methods Prospective, randomized, multicenter study
Participants 96 children aged 2 to 12 years; mean age 7.4 years. 51 males; 45 females
Interventions 1. Penicillin V 125 or 250 mg qds for 10 days
2. Azithromycin 10 mg/kg once a day for 3 days
Outcomes Assess clinical and bacteriological efficacy and safety
Notes Early follow-up: at days 2 to 3 and 9 to 11 of the study
Late follow-up: at day 29 to 31 of the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of random sequence generation
was not described
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Hamill 1993 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing outcome data
Allocation concealment (selection bias) Unclear risk Not mentioned
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
Kafetzis 2004
Methods Prospective, open-label, comparative, randomized study
Participants 179 children aged 3 to 13 years; mean age 6 years. 107 males; 72 females
Interventions 1. Penicillin V 50 mg/kg/day (800,000 IU/kg/day; max 1.2 million units/day) tds
for 10 days
2. Cefprozil 30 mg/kg/day; max 500 mg/day bid for 5 days
Outcomes Assess the difference in clinical and bacteriological efficacy, compliance and safety of
study medication
Notes Early follow-up: at day 12 to 15 of the study
Late follow-up: at day 28 to 30 of the study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “assigned by means of a computer random-
ized number”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
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Kafetzis 2004 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Reasons for missing outcome data unlikely
to be related to true outcome (for survival
data, censoring unlikely to be introducing
bias)
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
McCarty 2000
Methods Randomized, comparative, multicenter study
Participants 528 children aged 6 months to 12 years; mean age 90 months. 289 males; 239 females
Interventions 1. Penicillin V 13.3 mg/kg tid for 10 days
2. Clarithromycin 7.5 mg bid for 5 days
Outcomes Evaluate clinical and bacteriological efficacy, compliance and safety
Notes Early follow-up: at 1 to 4 days after completion of the antibiotic duration
Late follow-up: at 28 to 32 days after completion of the antibiotic duration
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
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McCarty 2000 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk For dichotomous outcome data, the pro-
portion of missing outcomes compared
with observed event risk enough to induce
clinically relevant bias in intervention ef-
fect estimate
Allocation concealment (selection bias) Unclear risk Not mentioned
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly





Interventions 1. Penicillin V for 10 days
2. Cefadroxil for 5 days
Outcomes Bacteriological efficacy only
Notes Early follow-up: at day 3 to 5 of antibiotic treatment
Late follow-up: at days 11 to 15 and 21 to 35 after completion of antibiotic treatment
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk Number of recruited participants not mentioned
Allocation concealment (selection bias) Unclear risk Not mentioned
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Milatovic 1991 (Continued)
Selective reporting (reporting bias) Low risk The study protocol was not available but it was clear that the
published results included all expected outcomes, particularly
those that were mentioned in the methods section
O’Doherty 1996a
Methods Randomized, double-blind study
Participants 489 children aged 2 to 13 years; mean age 7.7 years. 236 males; 253 females
Interventions 1. Penicillin V 125 to 250 mg qds for 10 days
2. Azithromycin 10 mg/kg od for 3 days
Outcomes Assess clinical and bacteriological response at the end of therapy (12 to 14 days) and late
(28 to 30 days). Assess treatment-related side effects in each treatment group
Notes Early follow-up: 2 to 4 days after completion of antibiotics
Late follow-up: 28 to 30 days after completion of antibiotics
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not mentioned




Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit judgement of
’low risk’; or ’high risk’
Incomplete outcome data (attrition bias)
All outcomes
High risk For dichotomous outcome data, the proportion of
missing outcomes compared with observed event
risk enough to induce clinically relevant bias in in-
tervention effect estimate
Allocation concealment (selection bias) Unclear risk Not mentioned
Selective reporting (reporting bias) Low risk The study protocol was not available but it was clear
that the published results included all expected out-
comes, particularly those that were mentioned in
the methods section
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O’Doherty 1996b
Methods Randomized, double-blind study
Participants 489 children aged 2 to 13 years, mean age 7.7 years. 236 males; 253 females
Interventions 1. Penicillin V 125 to 250 mg qds for 10 days
2. Azithromycin 20 mg/kg od for 3 days
Outcomes Assess clinical and bacteriological response at the end of therapy (12 to 14 days) and late
(28 to 30 days). Assess treatment-related side effects in each treatment group
Notes Early follow-up: 2 to 4 days after completion of antibiotics
Late follow-up: 28 to 30 days after completion of antibiotics
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not mentioned




Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit judgement of
’low risk’; or ’high risk’
Incomplete outcome data (attrition bias)
All outcomes
High risk For dichotomous outcome data, the proportion of
missing outcomes compared with observed event
risk enough to induce clinically relevant bias in in-
tervention effect estimate
Allocation concealment (selection bias) Unclear risk Not mentioned
Selective reporting (reporting bias) Low risk The study protocol was not available but it was clear
that the published results included all expected out-
comes, particularly those that were mentioned in
the methods section
Pacifico 1996
Methods Prospective, randomized, open study
Participants 183 children aged 3 to 12 years. 75 males; 79 females
Interventions 1. Penicillin V 50,000 IU in 2 divided doses for 10 days
2. Azithromycin 10 mg/kg/day od for 3 days
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Pacifico 1996 (Continued)
Outcomes Assess clinical and microbiological efficacy and safety
Notes Follow-up: at baseline, day 4 to 5, day 12 to 14 and day 34 to 36
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “according to computer generated randomised
schedule”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk For dichotomous outcome data, the proportion
of missing outcomes compared with observed
event risk enough to induce clinically relevant
bias in intervention effect estimate
Allocation concealment (selection bias) Unclear risk Not mentioned
Selective reporting (reporting bias) Low risk The study protocol was not available but it was
clear that the published results included all ex-
pected outcomes, particularly those that were
mentioned in the methods section
Pichichero 1994
Methods Prospective, randomized, observer-blind, multicenter study
Participants 484 children aged 2 to 17 years; mean age 8 years
Interventions 1. Penicillin V 40 mg/kg/day for 10 days
2. Cefpodoxime proxetil 10 mg/kg/day bid for 5 days
3. Cefpodoxime proxetil 10 mg/kg/day od for 10 days
Outcomes Assess bacteriological and clinical effect and safety
Notes Follow-up visit day 3 to 5, day 9 to 12, day 14 to 17, day 32 to 38
Risk of bias
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Pichichero 1994 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “this was an investigation blinded study”
Incomplete outcome data (attrition bias)
All outcomes
High risk For dichotomous outcome data, the pro-
portion of missing outcomes compared
with observed event risk enough to induce
clinically relevant bias in intervention ef-
fect estimate
Allocation concealment (selection bias) Unclear risk Not mentioned
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
Portier 2001
Methods Randomized, open study
Participants 325 children aged 2 to 15 years
Interventions 1. Penicillin 50,000 to 100,000 IU tid for 10 days
2. Josamycin 50 mg/kg/day bid for 5 days
Outcomes Clinical and microbiological response and tolerance assessment
Notes Follow-up visit: at the end of treatment, day 12, day 30
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not mentioned
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Portier 2001 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk For dichotomous outcome data, the proportion of missing
outcomes compared with observed event risk enough to in-
duce clinically relevant bias in intervention effect estimate
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but it was clear that
the published results included all expected outcomes, par-
ticularly those that were mentioned in the methods section
Schaad 1996
Methods Open, comparative, multicenter study
Participants 343 children aged 6 months to 14 years; mean age 7 years. 171 males; 172 females
Interventions 1. Penicillin V 100,000 IU = 56 mg/kg tid for 10 days
2. Azithromycin 10 mg/kg od for 3 days
Outcomes Clinical and microbiological response and tolerability
Notes Follow-up 10 to 14 and 20 to 30 days after the start of treatment
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “computer generated randomizations table”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
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Schaad 1996 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data balanced in numbers
across intervention groups, with similar rea-
sons for missing data across groups
Allocation concealment (selection bias) High risk Not mentioned
Selective reporting (reporting bias) Low risk The study protocol was not available but it
was clear that the published results included
all expected outcomes, particularly those that
were mentioned in the methods section
Schaad 2002
Methods Multicenter, randomized, comparative, open-label study
Participants 292 children aged 2 to 12 years
Interventions 1. Penicillin V 100,000 IU/kg/day tid for 10 days
2. Azithromycin 10 mg/kg/day od for 3 days
Outcomes Clinical and microbiological efficacy, antibiotic tolerance and adverse events
Notes Follow-up at study days 14 and 28
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “grading by laboratory personnel who were
blinded regarding the patient therapy”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data balanced in num-
bers across intervention groups, with simi-
lar reasons for missing data across groups
Allocation concealment (selection bias) High risk Open
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
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Schaad 2002 (Continued)
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
Scholz 2004
Methods Multicenter, randomized, open-label, comparative study
Participants 1975 children aged 1 to 17 years
Interventions 1. Penicillin V 50,000 IU/kg/day (30 mg/kg) tid for 10 days
2. Cefuroxime axetil 20 mg/kg/day (max 500 mg) bid for 5 days
Outcomes Clinical and bacteriological efficacy, safety and tolerance
Notes Follow-up:
Day 7 to 9 and 12 to 14 in short duration group
Day 12 to 14 and 17 to 19 in control group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data balanced in num-
bers across intervention groups, with simi-
lar reasons for missing data across groups
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
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Syrogiannopoulos 2004a
Methods Multicenter, randomized, comparative, open-label study
Participants 316 children aged 2 to 15 years
Interventions 1. Penicillin V 30 mg/kg/day tid for 10 days
2. Clarithromycin 30 mg/kg/day in 2 divided doses (max. 500 mg/dose) for 5 days
Outcomes Clinical and bacteriological efficacy and safety
Notes Follow-up: day 4 to 8 and 21 to 28 after completion of therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data balanced in num-
bers across intervention groups, with simi-
lar reasons for missing data across groups
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
Syrogiannopoulos 2004b
Methods Multicenter, randomized, comparative, open-label study
Participants 313 children aged 1 to 17 years
Interventions 1. Penicillin V 30 mg/kg/day in 3 divided doses for 10 days
2. Clarithromycin 15 mg/kg/day bid (max. 250 mg/bid) for 5 days
Outcomes Clinical and bacteriological efficacy and safety
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Syrogiannopoulos 2004b (Continued)
Notes Follow-up:day 4 to 8 and 21 to 28 after completion of therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data balanced in num-
bers across intervention groups, with simi-
lar reasons for missing data across groups
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly
those that were mentioned in the methods
section
Syrogiannopoulos 2004c
Methods Multicenter, randomized, comparative, open-label study
Participants 313 children aged 1 to 17 years
Interventions 1. Penicillin V 30 mg/kg/day tid for 10 days
2. Amoxicillin/clavulanate (43.8/6.2 mg/kg/day) bid (max. 1 g bid) for 5 days
Outcomes Clinical and bacteriological efficacy and safety
Notes Follow-up: day 4 to 8 and 21 to 28 after completion of therapy
Risk of bias
Bias Authors’ judgement Support for judgement
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Syrogiannopoulos 2004c (Continued)
Random sequence generation (selection
bias)
Unclear risk Insufficient information available
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data balanced in num-
bers across intervention groups, with simi-
lar reasons for missing data across groups
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but
it was clear that the published results in-
cluded all expected outcomes, particularly




Participants 482 children aged 1 to 12 years; median 7.7 years. 250 males; 232 females
Interventions 1. Penicillin V 10 mg/kg qds for 10 days
2. Cefdinir 7 mg/kg bid for 5 days
Outcomes Clinical and microbiological efficacy, antibiotic
Notes Early follow-up: 5 to 10 days after completing the duration of antibiotics
Late follow-up: study day 25 to 30
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Referring to a random number table
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
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Tack 1997 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “central lab had no knowledge of assigned prescription”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data balanced in numbers across inter-
vention groups, with similar reasons formissing data across
groups
Allocation concealment (selection bias) High risk Open-label
Selective reporting (reporting bias) Low risk The study protocol was not available but it was clear that
the published results included all expected outcomes, par-
ticularly those that were mentioned in themethods section
bid: twice a day
g: gram





qds: four times a day
RCT: randomized controlled trial
tid: three times a day
tds: three times a day
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Adam 2000b Replication of part of the data published in a larger study (Adam 2000a) which is included in the review
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D A T A A N D A N A L Y S E S
Comparison 1. Duration of clinical symptoms




participants Statistical method Effect size
1 Duration of fever 2 348 Mean Difference (IV, Fixed, 95% CI) -0.30 [-0.45, -0.14]
2 Duration of sore throat 1 188 Mean Difference (IV, Fixed, 95% CI) -0.5 [-0.78, -0.22]
Comparison 2. Clinical efficacy




participants Statistical method Effect size
1 Early clinical treatment failure 23 11713 Odds Ratio (M-H, Fixed, 95% CI) 0.80 [0.67, 0.94]
1.1 Azithromycin 10 mg/kg
(short) versus penicillin
(standard)
6 1366 Odds Ratio (M-H, Fixed, 95% CI) 1.05 [0.66, 1.66]
1.2 Azithromycin 20 mg/kg
(short) versus penicillin
(standard)
2 520 Odds Ratio (M-H, Fixed, 95% CI) 0.08 [0.01, 0.64]
1.3 Clarithromycin (short)
versus penicillin (standard)
3 1024 Odds Ratio (M-H, Fixed, 95% CI) 1.02 [0.55, 1.86]
1.4 Cefuroxime (short) versus
penicillin (standard)
2 2152 Odds Ratio (M-H, Fixed, 95% CI) 0.49 [0.30, 0.81]
1.5 Others 10 6651 Odds Ratio (M-H, Fixed, 95% CI) 0.86 [0.70, 1.06]








2 465 Odds Ratio (M-H, Fixed, 95% CI) 0.94 [0.42, 2.09]
2.3 Clarithromycin (short)
versus penicillin (standard)
3 932 Odds Ratio (M-H, Fixed, 95% CI) 1.26 [0.84, 1.88]
2.4 Cefuroxime (short) versus
penicillin (standard)
1 158 Odds Ratio (M-H, Fixed, 95% CI) 2.06 [0.48, 8.95]
2.5 Others 7 5644 Odds Ratio (M-H, Fixed, 95% CI) 0.87 [0.75, 1.01]
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Comparison 3. Bacteriological efficacy




participants Statistical method Effect size
1 Early bacteriological treatment
failure
23 11555 Odds Ratio (M-H, Fixed, 95% CI) 1.08 [0.97, 1.20]
1.1 Azithromycin 10 mg/kg
(short) versus penicillin
(standard)
6 1354 Odds Ratio (M-H, Fixed, 95% CI) 3.25 [2.47, 4.27]
1.2 Azithromycin 20 mg/kg
(short) versus penicillin
(standard)
2 520 Odds Ratio (M-H, Fixed, 95% CI) 0.29 [0.14, 0.61]
1.3 Clarithromycin (short)
versus penicillin (standard)
3 1034 Odds Ratio (M-H, Fixed, 95% CI) 1.32 [0.98, 1.77]
1.4 Cefuroxime (short) versus
penicillin (standard)
2 2111 Odds Ratio (M-H, Fixed, 95% CI) 0.64 [0.48, 0.87]
1.5 Others 10 6536 Odds Ratio (M-H, Fixed, 95% CI) 0.91 [0.79, 1.05]
2 Late bacteriological recurrence 24 10249 Odds Ratio (M-H, Fixed, 95% CI) 1.31 [1.16, 1.48]
2.1 Azithromycin 10 mg/kg
(short) versus penicillin
(standard)
6 1085 Odds Ratio (M-H, Fixed, 95% CI) 3.62 [2.66, 4.92]
2.2 Azithromycin 20 mg/kg
(short) versus penicillin
(standard)
2 437 Odds Ratio (M-H, Fixed, 95% CI) 1.03 [0.55, 1.96]
2.3 Clarithromycin (short)
versus penicillin (standard)
3 890 Odds Ratio (M-H, Fixed, 95% CI) 1.53 [1.12, 2.09]
2.4 Cefuroxime (short) versus
penicillin (standard)
2 1858 Odds Ratio (M-H, Fixed, 95% CI) 0.80 [0.57, 1.11]
2.5 Others 11 5979 Odds Ratio (M-H, Fixed, 95% CI) 1.02 [0.85, 1.23]
Comparison 4. Side effects




participants Statistical method Effect size
1 Side effects 21 7997 Odds Ratio (M-H, Fixed, 95% CI) 1.85 [1.55, 2.21]
1.1 Azithromycin 10 mg/kg
(short) versus penicillin
(standard)
6 1538 Odds Ratio (M-H, Fixed, 95% CI) 2.20 [1.49, 3.24]
1.2 Azithromycin 20 mg/kg
(short) versus penicillin
(standard)
2 653 Odds Ratio (M-H, Fixed, 95% CI) 5.13 [2.76, 9.54]
1.3 Clarithromycin (short)
versus penicillin (standard)
3 1157 Odds Ratio (M-H, Fixed, 95% CI) 1.77 [1.22, 2.58]
1.4 Cefuroxime (short) versus
penicillin (standard)
2 2331 Odds Ratio (M-H, Fixed, 95% CI) 1.88 [0.97, 3.62]
1.5 Others 8 2318 Odds Ratio (M-H, Fixed, 95% CI) 1.28 [0.95, 1.72]
39Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 5. Compliance




participants Statistical method Effect size
1 Non-compliance 6 1909 Odds Ratio (M-H, Fixed, 95% CI) 0.21 [0.16, 0.29]
Comparison 6. Complications




participants Statistical method Effect size
1 Complications 3 8135 Odds Ratio (M-H, Fixed, 95% CI) 0.53 [0.17, 1.64]
Analysis 1.1. Comparison 1 Duration of clinical symptoms, Outcome 1 Duration of fever.
Review: Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children
Comparison: 1 Duration of clinical symptoms
Outcome: 1 Duration of fever





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Aujard 1995 78 2.04 (0.85) 91 2.38 (1.17) 26.5 % -0.34 [ -0.65, -0.03 ]
Kafetzis 2004 88 2.82 (0.52) 91 3.1 (0.72) 73.5 % -0.28 [ -0.46, -0.10 ]
Total (95% CI) 166 182 100.0 % -0.30 [ -0.45, -0.14 ]
Heterogeneity: Chi2 = 0.11, df = 1 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 3.69 (P = 0.00023)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favors short term Favors standard duration
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Analysis 1.2. Comparison 1 Duration of clinical symptoms, Outcome 2 Duration of sore throat.
Review: Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children
Comparison: 1 Duration of clinical symptoms
Outcome: 2 Duration of sore throat





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Aujard 1995 88 2.19 (0.81) 100 2.69 (1.13) 100.0 % -0.50 [ -0.78, -0.22 ]
Total (95% CI) 88 100 100.0 % -0.50 [ -0.78, -0.22 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.52 (P = 0.00044)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Clinical efficacy, Outcome 1 Early clinical treatment failure.
Review: Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children
Comparison: 2 Clinical efficacy
Outcome: 1 Early clinical treatment failure
Study or subgroup Short duration Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Azithromycin 10 mg/kg (short) versus penicillin (standard)
Cohen 2002a 8/135 8/146 2.4 % 1.09 [ 0.40, 2.98 ]
Hamill 1993 1/41 0/44 0.2 % 3.30 [ 0.13, 83.23 ]
O’Doherty 1996a 1/123 4/132 1.3 % 0.26 [ 0.03, 2.38 ]
Pacifico 1996 11/76 5/78 1.4 % 2.47 [ 0.82, 7.49 ]
Schaad 1996 11/160 17/160 5.2 % 0.62 [ 0.28, 1.37 ]
Schaad 2002 7/141 4/130 1.3 % 1.65 [ 0.47, 5.76 ]
Subtotal (95% CI) 676 690 11.6 % 1.05 [ 0.66, 1.66 ]
Total events: 39 (Short duration), 38 (Standard duration)
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Study or subgroup Short duration Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 6.48, df = 5 (P = 0.26); I2 =23%
Test for overall effect: Z = 0.19 (P = 0.85)
2 Azithromycin 20 mg/kg (short) versus penicillin (standard)
Cohen 2002b 0/139 8/146 2.7 % 0.06 [ 0.00, 1.02 ]
O’Doherty 1996b 0/103 4/132 1.3 % 0.14 [ 0.01, 2.59 ]
Subtotal (95% CI) 242 278 4.0 % 0.08 [ 0.01, 0.64 ]
Total events: 0 (Short duration), 12 (Standard duration)
Heterogeneity: Chi2 = 0.17, df = 1 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 2.39 (P = 0.017)
3 Clarithromycin (short) versus penicillin (standard)
McCarty 2000 8/252 15/235 4.9 % 0.48 [ 0.20, 1.16 ]
Syrogiannopoulos 2004a 6/135 3/135 0.9 % 2.05 [ 0.50, 8.36 ]
Syrogiannopoulos 2004b 8/132 3/135 0.9 % 2.84 [ 0.74, 10.94 ]
Subtotal (95% CI) 519 505 6.8 % 1.02 [ 0.55, 1.86 ]
Total events: 22 (Short duration), 21 (Standard duration)
Heterogeneity: Chi2 = 5.97, df = 2 (P = 0.05); I2 =67%
Test for overall effect: Z = 0.05 (P = 0.96)
4 Cefuroxime (short) versus penicillin (standard)
Aujard 1995 5/97 4/103 1.2 % 1.35 [ 0.35, 5.16 ]
Scholz 2004 15/496 99/1456 15.9 % 0.43 [ 0.25, 0.74 ]
Subtotal (95% CI) 593 1559 17.1 % 0.49 [ 0.30, 0.81 ]
Total events: 20 (Short duration), 103 (Standard duration)
Heterogeneity: Chi2 = 2.40, df = 1 (P = 0.12); I2 =58%
Test for overall effect: Z = 2.79 (P = 0.0053)
5 Others
Adam 1995 3/75 2/76 0.6 % 1.54 [ 0.25, 9.50 ]
Adam 1996 2/102 2/99 0.7 % 0.97 [ 0.13, 7.02 ]
Adam 2000a 167/3028 93/1412 39.2 % 0.83 [ 0.64, 1.08 ]
Cohen 1996 13/141 15/136 4.5 % 0.82 [ 0.37, 1.79 ]
Gerber 1987 6/99 6/73 2.1 % 0.72 [ 0.22, 2.33 ]
Kafetzis 2004 1/88 1/91 0.3 % 1.03 [ 0.06, 16.80 ]
Pichichero 1994 9/161 12/163 3.7 % 0.75 [ 0.31, 1.82 ]
Portier 2001 11/114 7/83 2.4 % 1.16 [ 0.43, 3.13 ]
Syrogiannopoulos 2004c 4/135 3/135 1.0 % 1.34 [ 0.29, 6.12 ]
Tack 1997 19/224 20/216 6.1 % 0.91 [ 0.47, 1.75 ]
Subtotal (95% CI) 4167 2484 60.5 % 0.86 [ 0.70, 1.06 ]
Total events: 235 (Short duration), 161 (Standard duration)
Heterogeneity: Chi2 = 1.42, df = 9 (P = 1.00); I2 =0.0%
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Study or subgroup Short duration Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 1.43 (P = 0.15)
Total (95% CI) 6197 5516 100.0 % 0.80 [ 0.67, 0.94 ]
Total events: 316 (Short duration), 335 (Standard duration)
Heterogeneity: Chi2 = 26.06, df = 22 (P = 0.25); I2 =16%
Test for overall effect: Z = 2.66 (P = 0.0078)
Test for subgroup differences: Chi2 = 10.58, df = 4 (P = 0.03), I2 =62%
0.001 0.01 0.1 1 10 100 1000
Favors short term Favors standard duration
Analysis 2.2. Comparison 2 Clinical efficacy, Outcome 2 Late clinical recurrence.
Review: Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children
Comparison: 2 Clinical efficacy
Outcome: 2 Late clinical recurrence
Study or subgroup Short duration Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Azithromycin 10mg/kg (short) versus penicillin (standard)
Cohen 2002a 12/118 11/130 2.1 % 1.22 [ 0.52, 2.89 ]
O’Doherty 1996a 5/106 2/108 0.4 % 2.62 [ 0.50, 13.83 ]
Pacifico 1996 8/65 2/73 0.4 % 4.98 [ 1.02, 24.39 ]
Schaad 2002 8/139 7/130 1.5 % 1.07 [ 0.38, 3.05 ]
Subtotal (95% CI) 428 441 4.3 % 1.62 [ 0.93, 2.83 ]
Total events: 33 (Short duration), 22 (Standard duration)
Heterogeneity: Chi2 = 3.25, df = 3 (P = 0.35); I2 =8%
Test for overall effect: Z = 1.70 (P = 0.090)
2 Azithromycin 20mg/kg (short) versus penicillin (standard)
Cohen 2002b 7/134 11/130 2.3 % 0.60 [ 0.22, 1.59 ]
O’Doherty 1996b 5/93 2/108 0.4 % 3.01 [ 0.57, 15.90 ]
Subtotal (95% CI) 227 238 2.7 % 0.94 [ 0.42, 2.09 ]
Total events: 12 (Short duration), 13 (Standard duration)
0.02 0.1 1 10 50
Favors short Favors standard
(Continued . . . )
43Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup Short duration Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 2.71, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 0.15 (P = 0.88)
3 Clarithromycin (short) versus penicillin (standard)
McCarty 2000 43/231 37/211 6.9 % 1.08 [ 0.66, 1.75 ]
Syrogiannopoulos 2004a 7/125 6/124 1.2 % 1.17 [ 0.38, 3.58 ]
Syrogiannopoulos 2004b 13/117 6/124 1.1 % 2.46 [ 0.90, 6.70 ]
Subtotal (95% CI) 473 459 9.3 % 1.26 [ 0.84, 1.88 ]
Total events: 63 (Short duration), 49 (Standard duration)
Heterogeneity: Chi2 = 2.13, df = 2 (P = 0.34); I2 =6%
Test for overall effect: Z = 1.11 (P = 0.27)
4 Cefuroxime (short) versus penicillin (standard)
Aujard 1995 5/72 3/86 0.6 % 2.06 [ 0.48, 8.95 ]
Subtotal (95% CI) 72 86 0.6 % 2.06 [ 0.48, 8.95 ]
Total events: 5 (Short duration), 3 (Standard duration)
Heterogeneity: not applicable
Test for overall effect: Z = 0.97 (P = 0.33)
5 Others
Adam 1995 6/75 8/76 1.6 % 0.74 [ 0.24, 2.24 ]
Adam 1996 10/102 6/99 1.2 % 1.68 [ 0.59, 4.83 ]
Adam 2000a 565/3052 305/1430 74.2 % 0.84 [ 0.72, 0.98 ]
Cohen 1996 9/111 6/105 1.2 % 1.46 [ 0.50, 4.24 ]
Kafetzis 2004 11/88 14/91 2.6 % 0.79 [ 0.34, 1.84 ]
Portier 2001 7/83 5/78 1.0 % 1.34 [ 0.41, 4.43 ]
Syrogiannopoulos 2004c 8/130 6/124 1.3 % 1.29 [ 0.43, 3.83 ]
Subtotal (95% CI) 3641 2003 83.1 % 0.87 [ 0.75, 1.01 ]
Total events: 616 (Short duration), 350 (Standard duration)
Heterogeneity: Chi2 = 3.78, df = 6 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 1.88 (P = 0.060)
Total (95% CI) 4841 3227 100.0 % 0.95 [ 0.83, 1.08 ]
Total events: 729 (Short duration), 437 (Standard duration)
Heterogeneity: Chi2 = 18.86, df = 16 (P = 0.28); I2 =15%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Chi2 = 7.86, df = 4 (P = 0.10), I2 =49%
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Analysis 3.1. Comparison 3 Bacteriological efficacy, Outcome 1 Early bacteriological treatment failure.
Review: Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children
Comparison: 3 Bacteriological efficacy
Outcome: 1 Early bacteriological treatment failure
Study or subgroup Short term Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Azithromycin 10 mg/kg (short) versus penicillin (standard)
Cohen 2002a 57/135 23/146 1.8 % 3.91 [ 2.23, 6.85 ]
Hamill 1993 2/41 2/44 0.3 % 1.08 [ 0.14, 8.02 ]
O’Doherty 1996a 2/123 11/132 1.5 % 0.18 [ 0.04, 0.84 ]
Pacifico 1996 24/76 7/78 0.7 % 4.68 [ 1.88, 11.69 ]
Schaad 1996 53/152 28/156 2.6 % 2.45 [ 1.44, 4.15 ]
Schaad 2002 87/141 25/130 1.4 % 6.77 [ 3.89, 11.76 ]
Subtotal (95% CI) 668 686 8.3 % 3.25 [ 2.47, 4.27 ]
Total events: 225 (Short term), 96 (Standard duration)
Heterogeneity: Chi2 = 23.76, df = 5 (P = 0.00024); I2 =79%
Test for overall effect: Z = 8.39 (P < 0.00001)
2 Azithromycin 20 mg/kg (short) versus penicillin (standard)
Cohen 2002b 8/139 23/146 3.0 % 0.33 [ 0.14, 0.76 ]
O’Doherty 1996b 2/103 11/132 1.4 % 0.22 [ 0.05, 1.01 ]
Subtotal (95% CI) 242 278 4.4 % 0.29 [ 0.14, 0.61 ]
Total events: 10 (Short term), 34 (Standard duration)
Heterogeneity: Chi2 = 0.21, df = 1 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 3.27 (P = 0.0011)
3 Clarithromycin (short) versus penicillin (standard)
McCarty 2000 15/253 54/244 7.4 % 0.22 [ 0.12, 0.41 ]
Syrogiannopoulos 2004a 52/135 21/135 1.9 % 3.40 [ 1.90, 6.08 ]
Syrogiannopoulos 2004b 54/132 21/135 1.8 % 3.76 [ 2.10, 6.72 ]
Subtotal (95% CI) 520 514 11.1 % 1.32 [ 0.98, 1.77 ]
Total events: 121 (Short term), 96 (Standard duration)
Heterogeneity: Chi2 = 56.32, df = 2 (P<0.00001); I2 =96%
Test for overall effect: Z = 1.85 (P = 0.065)
4 Cefuroxime (short) versus penicillin (standard)
Aujard 1995 16/97 16/103 1.9 % 1.07 [ 0.50, 2.29 ]
Scholz 2004 49/490 225/1421 15.0 % 0.59 [ 0.43, 0.82 ]
Subtotal (95% CI) 587 1524 16.8 % 0.64 [ 0.48, 0.87 ]
Total events: 65 (Short term), 241 (Standard duration)
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Study or subgroup Short term Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 2.03, df = 1 (P = 0.15); I2 =51%
Test for overall effect: Z = 2.89 (P = 0.0038)
5 Others
Adam 1995 12/69 8/68 1.0 % 1.58 [ 0.60, 4.15 ]
Adam 1996 17/102 12/99 1.5 % 1.45 [ 0.65, 3.22 ]
Adam 2000a 501/3002 215/1380 35.3 % 1.09 [ 0.91, 1.29 ]
Cohen 1996 23/141 20/136 2.5 % 1.13 [ 0.59, 2.17 ]
Gerber 1987 6/73 7/99 0.8 % 1.18 [ 0.38, 3.66 ]
Kafetzis 2004 2/88 12/91 1.7 % 0.15 [ 0.03, 0.71 ]
Pichichero 1994 11/126 27/130 3.5 % 0.36 [ 0.17, 0.77 ]
Portier 2001 20/113 22/109 2.7 % 0.85 [ 0.43, 1.67 ]
Syrogiannopoulos 2004c 20/135 21/135 2.6 % 0.94 [ 0.49, 1.84 ]
Tack 1997 23/224 61/216 8.0 % 0.29 [ 0.17, 0.49 ]
Subtotal (95% CI) 4073 2463 59.4 % 0.91 [ 0.79, 1.05 ]
Total events: 635 (Short term), 405 (Standard duration)
Heterogeneity: Chi2 = 36.33, df = 9 (P = 0.00003); I2 =75%
Test for overall effect: Z = 1.28 (P = 0.20)
Total (95% CI) 6090 5465 100.0 % 1.08 [ 0.97, 1.20 ]
Total events: 1056 (Short term), 872 (Standard duration)
Heterogeneity: Chi2 = 211.35, df = 22 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.45 (P = 0.15)
Test for subgroup differences: Chi2 = 92.55, df = 4 (P = 0.00), I2 =96%
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Analysis 3.2. Comparison 3 Bacteriological efficacy, Outcome 2 Late bacteriological recurrence.
Review: Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children
Comparison: 3 Bacteriological efficacy
Outcome: 2 Late bacteriological recurrence
Study or subgroup Short term Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Azithromycin 10 mg/kg (short) versus penicillin (standard)
Cohen 2002a 30/74 15/114 1.6 % 4.50 [ 2.20, 9.19 ]
Hamill 1993 5/37 3/40 0.6 % 1.93 [ 0.43, 8.70 ]
O’Doherty 1996a 6/106 6/108 1.3 % 1.02 [ 0.32, 3.27 ]
Pacifico 1996 11/51 4/71 0.6 % 4.61 [ 1.37, 15.44 ]
Schaad 1996 42/93 24/120 2.6 % 3.29 [ 1.80, 6.04 ]
Schaad 2002 97/141 42/130 3.1 % 4.62 [ 2.77, 7.71 ]
Subtotal (95% CI) 502 583 9.9 % 3.62 [ 2.66, 4.92 ]
Total events: 191 (Short term), 94 (Standard duration)
Heterogeneity: Chi2 = 6.69, df = 5 (P = 0.24); I2 =25%
Test for overall effect: Z = 8.18 (P < 0.00001)
2 Azithromycin 20 mg/kg (short) versus penicillin (standard)
Cohen 2002b 18/122 15/114 3.0 % 1.14 [ 0.55, 2.39 ]
O’Doherty 1996b 4/93 6/108 1.2 % 0.76 [ 0.21, 2.79 ]
Subtotal (95% CI) 215 222 4.3 % 1.03 [ 0.55, 1.96 ]
Total events: 22 (Short term), 21 (Standard duration)
Heterogeneity: Chi2 = 0.28, df = 1 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 0.10 (P = 0.92)
3 Clarithromycin (short) versus penicillin (standard)
McCarty 2000 43/231 37/211 7.2 % 1.08 [ 0.66, 1.75 ]
Syrogiannopoulos 2004a 39/114 26/114 3.9 % 1.76 [ 0.98, 3.16 ]
Syrogiannopoulos 2004b 42/106 26/114 3.5 % 2.22 [ 1.24, 3.99 ]
Subtotal (95% CI) 451 439 14.7 % 1.53 [ 1.12, 2.09 ]
Total events: 124 (Short term), 89 (Standard duration)
Heterogeneity: Chi2 = 3.80, df = 2 (P = 0.15); I2 =47%
Test for overall effect: Z = 2.67 (P = 0.0076)
4 Cefuroxime (short) versus penicillin (standard)
Aujard 1995 4/72 7/86 1.4 % 0.66 [ 0.19, 2.37 ]
Scholz 2004 48/434 169/1266 17.7 % 0.81 [ 0.57, 1.14 ]
Subtotal (95% CI) 506 1352 19.1 % 0.80 [ 0.57, 1.11 ]
Total events: 52 (Short term), 176 (Standard duration)
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Study or subgroup Short term Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 0.08, df = 1 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 1.35 (P = 0.18)
5 Others
Adam 1995 6/75 8/76 1.7 % 0.74 [ 0.24, 2.24 ]
Adam 1996 25/102 24/99 4.2 % 1.01 [ 0.53, 1.93 ]
Adam 2000a 208/2667 83/1229 24.1 % 1.17 [ 0.90, 1.52 ]
Cohen 1996 11/111 6/105 1.3 % 1.82 [ 0.65, 5.10 ]
Gerber 1987 14/73 8/99 1.3 % 2.70 [ 1.07, 6.83 ]
Kafetzis 2004 7/88 23/91 4.8 % 0.26 [ 0.10, 0.63 ]
Milatovic 1991 16/104 16/105 3.1 % 1.01 [ 0.48, 2.15 ]
Pichichero 1994 13/126 18/130 3.7 % 0.72 [ 0.33, 1.53 ]
Portier 2001 10/83 10/78 2.1 % 0.93 [ 0.37, 2.38 ]
Syrogiannopoulos 2004c 21/123 26/114 5.2 % 0.70 [ 0.37, 1.32 ]
Tack 1997 7/171 3/130 0.8 % 1.81 [ 0.46, 7.13 ]
Subtotal (95% CI) 3723 2256 52.1 % 1.02 [ 0.85, 1.23 ]
Total events: 338 (Short term), 225 (Standard duration)
Heterogeneity: Chi2 = 18.62, df = 10 (P = 0.05); I2 =46%
Test for overall effect: Z = 0.24 (P = 0.81)
Total (95% CI) 5397 4852 100.0 % 1.31 [ 1.16, 1.48 ]
Total events: 727 (Short term), 605 (Standard duration)
Heterogeneity: Chi2 = 87.52, df = 23 (P<0.00001); I2 =74%
Test for overall effect: Z = 4.26 (P = 0.000020)
Test for subgroup differences: Chi2 = 58.98, df = 4 (P = 0.00), I2 =93%
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Analysis 4.1. Comparison 4 Side effects, Outcome 1 Side effects.
Review: Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children
Comparison: 4 Side effects
Outcome: 1 Side effects
Study or subgroup Short term Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Azithromycin 10 mg/kg (short) versus penicillin (standard)
Cohen 2002a 31/169 5/166 2.3 % 7.23 [ 2.74, 19.11 ]
Hamill 1993 2/41 0/44 0.3 % 5.63 [ 0.26, 120.91 ]
O’Doherty 1996a 15/166 8/163 4.1 % 1.92 [ 0.79, 4.67 ]
Pacifico 1996 8/93 5/90 2.6 % 1.60 [ 0.50, 5.09 ]
Schaad 1996 23/164 16/173 7.5 % 1.60 [ 0.81, 3.15 ]
Schaad 2002 4/139 6/130 3.4 % 0.61 [ 0.17, 2.22 ]
Subtotal (95% CI) 772 766 20.0 % 2.20 [ 1.49, 3.24 ]
Total events: 83 (Short term), 40 (Standard duration)
Heterogeneity: Chi2 = 11.13, df = 5 (P = 0.05); I2 =55%
Test for overall effect: Z = 3.96 (P = 0.000075)
2 Azithromycin 20 mg/kg (short) versus penicillin (standard)
Cohen 2002b 37/164 5/166 2.1 % 9.38 [ 3.58, 24.56 ]
O’Doherty 1996b 20/160 8/163 3.9 % 2.77 [ 1.18, 6.48 ]
Subtotal (95% CI) 324 329 6.0 % 5.13 [ 2.76, 9.54 ]
Total events: 57 (Short term), 13 (Standard duration)
Heterogeneity: Chi2 = 3.53, df = 1 (P = 0.06); I2 =72%
Test for overall effect: Z = 5.16 (P < 0.00001)
3 Clarithromycin (short) versus penicillin (standard)
McCarty 2000 35/268 32/260 15.7 % 1.07 [ 0.64, 1.79 ]
Syrogiannopoulos 2004a 25/158 8/158 3.8 % 3.52 [ 1.54, 8.08 ]
Syrogiannopoulos 2004b 21/155 8/158 3.8 % 2.94 [ 1.26, 6.85 ]
Subtotal (95% CI) 581 576 23.3 % 1.77 [ 1.22, 2.58 ]
Total events: 81 (Short term), 48 (Standard duration)
Heterogeneity: Chi2 = 7.72, df = 2 (P = 0.02); I2 =74%
Test for overall effect: Z = 2.97 (P = 0.0029)
4 Cefuroxime (short) versus penicillin (standard)
Aujard 1995 3/145 4/147 2.2 % 0.76 [ 0.17, 3.44 ]
Scholz 2004 13/496 17/1543 4.5 % 2.42 [ 1.17, 5.01 ]
Subtotal (95% CI) 641 1690 6.7 % 1.88 [ 0.97, 3.62 ]
Total events: 16 (Short term), 21 (Standard duration)
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Study or subgroup Short term Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 1.85, df = 1 (P = 0.17); I2 =46%
Test for overall effect: Z = 1.87 (P = 0.061)
5 Others
Adam 1995 5/75 6/76 3.1 % 0.83 [ 0.24, 2.86 ]
Adam 1996 10/115 8/112 4.1 % 1.24 [ 0.47, 3.26 ]
Cohen 1996 4/160 8/158 4.4 % 0.48 [ 0.14, 1.63 ]
Kafetzis 2004 4/88 3/91 1.6 % 1.40 [ 0.30, 6.43 ]
Pichichero 1994 11/161 6/163 3.1 % 1.92 [ 0.69, 5.32 ]
Portier 2001 24/168 16/156 7.9 % 1.46 [ 0.74, 2.86 ]
Syrogiannopoulos 2004c 23/155 8/158 3.8 % 3.27 [ 1.41, 7.55 ]
Tack 1997 30/240 33/242 16.0 % 0.90 [ 0.53, 1.54 ]
Subtotal (95% CI) 1162 1156 44.0 % 1.28 [ 0.95, 1.72 ]
Total events: 111 (Short term), 88 (Standard duration)
Heterogeneity: Chi2 = 10.15, df = 7 (P = 0.18); I2 =31%
Test for overall effect: Z = 1.64 (P = 0.10)
Total (95% CI) 3480 4517 100.0 % 1.85 [ 1.55, 2.21 ]
Total events: 348 (Short term), 210 (Standard duration)
Heterogeneity: Chi2 = 48.95, df = 20 (P = 0.00031); I2 =59%
Test for overall effect: Z = 6.71 (P < 0.00001)
Test for subgroup differences: Chi2 = 17.14, df = 4 (P = 0.00), I2 =77%
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Analysis 5.1. Comparison 5 Compliance, Outcome 1 Non-compliance.
Review: Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children
Comparison: 5 Compliance
Outcome: 1 Non-compliance
Study or subgroup Short term Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adam 1996 3/102 13/99 6.1 % 0.20 [ 0.06, 0.73 ]
Aujard 1995 3/97 7/103 3.1 % 0.44 [ 0.11, 1.74 ]
Cohen 1996 20/159 50/153 21.2 % 0.30 [ 0.17, 0.53 ]
Cohen 2002a 9/169 63/167 28.5 % 0.09 [ 0.04, 0.19 ]
Cohen 2002b 10/165 63/167 28.0 % 0.11 [ 0.05, 0.22 ]
McCarty 2000 16/268 29/260 13.2 % 0.51 [ 0.27, 0.96 ]
Total (95% CI) 960 949 100.0 % 0.21 [ 0.16, 0.29 ]
Total events: 61 (Short term), 225 (Standard duration)
Heterogeneity: Chi2 = 17.91, df = 5 (P = 0.003); I2 =72%
Test for overall effect: Z = 10.13 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 6.1. Comparison 6 Complications, Outcome 1 Complications.
Review: Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children
Comparison: 6 Complications
Outcome: 1 Complications
Study or subgroup Short term Standard duration Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Adam 2000a 4/4482 1/1430 18.0 % 1.28 [ 0.14, 11.43 ]
Schaad 2002 2/141 6/130 73.0 % 0.30 [ 0.06, 1.50 ]
Scholz 2004 0/496 1/1456 9.0 % 0.98 [ 0.04, 24.03 ]
Total (95% CI) 5119 3016 100.0 % 0.53 [ 0.17, 1.64 ]
Total events: 6 (Short term), 8 (Standard duration)
Heterogeneity: Chi2 = 1.25, df = 2 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 1.10 (P = 0.27)
Test for subgroup differences: Not applicable
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9 exp Streptococcal Infections/
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11 or/9-10
12 exp Anti-Bacterial Agents/
13 antibiotic$.mp.
14 or/12-13
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Appendix 2. MEDLINE (Ovid) search strategy
1 exp Pharyngitis/ (12360)
2 pharyngit*.tw. (3621)
3 Nasopharyngitis/ (236)
4 (nasopharyngit* or rhinopharyngit*).tw. (395)
5 tonsillit*.tw. (3760)
6 tonsillopharyngit*.tw. (224)
7 Respiratory Tract Infections/ (28349)
8 (infection* adj3 upper respiratory).tw. (5356)
9 (throat* adj2 (sore or infect* or inflamm*)).tw. (3240)
10 or/1-9 (46689)
11 Streptococcal Infections/ (25873)
12 Streptococcus/ (18995)




17 10 and 16 (6539)
18 exp Anti-Bacterial Agents/ (1110397)
19 antibiotic*.tw. (188878)
20 18 or 19 (1178879)
21 17 and 20 (3387)
Appendix 3. EMBASE.com search strategy
#28 #27 AND [embase]/lim AND [1-9-2007]/sd NOT [1-9-2011]/sd 43
#27 #23 AND #26 386
#26 #24 OR #25 926167
#25 random*:ab,ti OR placebo*:ab,ti OR factorial*:ab,ti OR crossover*:ab,ti OR ’cross over’:ab,ti OR ’cross-over’:ab,ti OR volunteer*:
ab,ti OR assign*:ab,ti OR allocat*:ab,ti OR ((singl* OR doubl*) NEXT/1 blind*):ab,ti AND [embase]/lim 885121
#24 ’randomised controlled trial’/exp OR ’single blind procedure’/exp OR ’double blind procedure’/exp OR ’crossover procedure’/exp
AND [embase]/lim 255122
#23 #19 AND #22 3231
#22 #20 OR #21 783193
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#21 antibiotic*:ab,ti AND [embase]/lim 187075
#20 ’antibiotic agent’/exp AND [embase]/lim 739261
#19 #17 OR #18 5126
#18 ’streptococcal pharyngitis’/de AND [embase]/lim 299
#17 #11 AND #16 5000
#16 #12 OR #13 OR #14 OR #15 71450
#15 gabhs:ab,ti AND [embase]/lim 350
#14 streptococc*:ab,ti AND [embase]/lim 58052
#13 ’streptococcus’/de OR ’streptococcus pyogenes’/de OR ’streptococcus group a’/de AND [embase]/lim 25767
#12 ’streptococcus infection’/de OR ’group a streptococcal infection’/de AND [embase]/lim 10886
#11 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 34248
#10 ’sore throat’/de AND [embase]/lim OR (throat* NEAR/2 (sore OR infect* OR inflamm*)):ab,ti AND [embase]/lim 3687
#9 (infection* NEAR/3 ’upper respiratory’):ab,ti AND [embase]/lim 5944
#8 ’upper respiratory tract infection’/de AND [embase]/lim12131
#7 tonsillopharyngit*:ab,ti AND [embase]/lim 272
#6 tonsillit*:ab,ti AND [embase]/lim 3132
#5 ’tonsillitis’/exp AND [embase]/lim 6700
#4 nasopharyngit*:ab,ti OR rhinopharyngit*:ab,ti AND [embase]/lim 606
#3 ’rhinopharyngitis’/de AND [embase]/lim 4118
#2 pharyngit*:ab,ti AND [embase]/lim 3740
#1 ’pharyngitis’/exp AND [embase]/lim 14192
WH A T ’ S N E W
Last assessed as up-to-date: 3 April 2012.
Date Event Description
3 April 2012 New citation required but conclusions have not changed Our conclusions remain unchanged
3 April 2012 New search has been performed Searches updated. We did not identify any new eligible
trials for inclusion or exclusion
H I S T O R Y
Protocol first published: Issue 3, 2004
Review first published: Issue 1, 2009
Date Event Description
17 February 2008 Amended Converted to new review format.
12 November 2007 New search has been performed Searches conducted.
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SA was responsible for preparing the text of the review.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• Department of Emergency Medicine, King Khalid University Hospital, King Saud University, Saudi Arabia.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We found most articles using a unified terminology for the late clinical and bacteriological outcomes, which was different to the
terminology we initially used in the protocol. We used “late clinical and bacteriological failure”, while most studies used “late clinical
and bacteriological recurrence”, which is a more accurate term, since failure was defined mostly as “persistence after treatment” while
recurrence is “return of the initial clinical or bacteriological infection after an initial resolution”.We felt that it would bemore appropriate
to adopt the same late outcome terminology used by most original studies: “late clinical and late bacteriological recurrence”. This
change of terminology on its own did not lead to a change in the outcome data, however, we removed the “recurrence” outcome, as it
is now redundant.
In the protocol we planned to assess heterogeneity using subgroup analyses. However, due to the limited number of trials that assessed the
same drug for short treatment we focused on the overall effect. In the Data and analyses section we included the effect per drug for four
subsets of studies based on the type of short duration antibiotic used: azithromycin 10 mg/kg, azithromycin 20 mg/kg, clarithromycin
and cefuroxime.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Streptococcus pyogenes; Acute Disease; Administration, Oral; Anti-Bacterial Agents [∗administration & dosage]; Azithromycin [ad-
ministration & dosage]; Drug Administration Schedule; Penicillins [∗administration & dosage]; Pharyngitis [complications; ∗drug
therapy; microbiology]; Randomized Controlled Trials as Topic; Recurrence; Streptococcal Infections [complications; ∗drug therapy;
microbiology]; Tonsillitis [drug therapy; microbiology]
MeSH check words
Adolescent; Child; Child, Preschool; Humans; Infant
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